Pudong New Area in Shanghai will provide better services and create better business environment for local foreign-invested companies, said Weng Zuliang, Party secretary of Pudong, during a meeting with Alexandre Merieux, CEO of BioMerieux, on Sept 27.

BioMerieux, founded in 1963, is France's largest in vitro diagnosis company. It set up a biotechnology subsidiary in Pudong in 2005, and located its production and R&D department in Zhangjiang Science City. And recently, its Pudong branch was upgraded to become the regional headquarters in China.

Weng expressed gratitude for the company's contributions to Pudong's social and economic development.

He said that their goals this year are to make the regional GDP exceed 1 trillion yuan ($144.9 billion), the general financial revenue exceed 400 billion yuan, and foreign trade volume exceed 2 trillion yuan.

Merieux said that he expected their business to grow further in China, and declared to increase their investment in R&D and to make more contributions to China's health care sector.

BioMerieux in Pudong New Area, Shanghai. [Photo/biomerieux.com.cn]